Skip to content
10-Q

Quarterly Report

VitaNova Life Sciences Corporation VNOV

0001683168-25-006918

← back to feed
Filed
Sep 12, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · Sep 12, 2025 25.01M sh
Shares Diluted Q1 2026 · Jul 31, 2025 25.01M sh
Shares Diluted Q1 2026 · Jul 31, 2024 25.01M sh
Operating Cash Flow Q1 2026 · Jul 31, 2025 $263.81K
Operating Cash Flow Q1 2026 · Jul 31, 2024 −$504K
Stockholders Equity Q1 2026 · Jul 31, 2025 $1.86M
Stockholders Equity Q1 2026 · Apr 30, 2025 $1.91M
Stockholders Equity Q1 2026 · Jul 31, 2024 $1M
Stockholders Equity Q1 2026 · Apr 30, 2024 $1.06M
Current Liabilities Q1 2026 · Jul 31, 2025 $379.98K
Current Liabilities Q1 2026 · Apr 30, 2025 $347.57K
Total Liabilities Q1 2026 · Jul 31, 2025 $379.98K
Total Liabilities Q1 2026 · Apr 30, 2025 $347.57K
Current Assets Q1 2026 · Jul 31, 2025 $2.24M
Current Assets Q1 2026 · Apr 30, 2025 $2.26M
Total Assets Q1 2026 · Jul 31, 2025 $2.24M
Total Assets Q1 2026 · Apr 30, 2025 $2.26M
Eps Diluted Q1 2026 · Jul 31, 2025 $0.00
Eps Diluted Q1 2026 · Jul 31, 2024 $0.00
Eps Basic Q1 2026 · Jul 31, 2025 $0.00
Eps Basic Q1 2026 · Jul 31, 2024 $0.00
Sga Expense Q1 2026 · Jul 31, 2025 $66.29K
Sga Expense Q1 2026 · Jul 31, 2024 $57.57K
Net Income Q1 2026 · Jul 31, 2025 −$46.3K
Net Income Q1 2026 · Jul 31, 2024 −$55.21K
Operating Income Q1 2026 · Jul 31, 2025 −$32.44K
Operating Income Q1 2026 · Jul 31, 2024 −$45.41K
Gross Profit Q1 2026 · Jul 31, 2025 $68.78K
Gross Profit Q1 2026 · Jul 31, 2024 $73.17K
Cost Of Revenue Q1 2026 · Jul 31, 2025 $35.12K
Cost Of Revenue Q1 2026 · Jul 31, 2024 $35.3K
Revenue Q1 2026 · Jul 31, 2025 $103.9K
Revenue Q1 2026 · Jul 31, 2024 $108.48K